3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
11
Burkitt Lymphoma
8
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Smoldering Multiple Myeloma
2
Lymphoma, Mantle-Cell
2
Immunoglobulin Light-chain Amyloidosis
2
Down Syndrome
2
Neoplasm Metastasis
1
Lung Neoplasms
1
Leukemia, Plasma Cell
1
Leukemia, Biphenotypic, Acute
1
Carcinoma, Non-Small-Cell Lung
1
Brain Neoplasms
1
Ann Arbor Stage II Mantle Cell Lymphoma
1
Interventions
venetoclax
18
Rituximab
14
ibrutinib
13
acalabrutinib
11
obinutuzumab
10
Specimen Handling
10
Cyclophosphamide
9
Biopsy
9
zanubrutinib
8
pirtobrutinib
6
Magnetic Resonance Spectroscopy
5
Lenalidomide
5
idelalisib
4
fludarabine phosphate
4
Cyclosporine
4
CT-P10
4
Bendamustine Hydrochloride
4
ARQ531
4
Whole-Body Irradiation
3
Vincristine
3
Sirolimus
3
Prednisone
3
Mycophenolic Acid
3
Doxorubicin
3
tafasitamab
2
pembrolizumab
2
fludarabine
2
Immunoglobulins
2
Disulfides
2
Cyclosporins
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Lymphocytic, Chronic, B-Cell
×
dexamethasone 21-phosphate
×
30 days
×
Clear all
No trials found.